MRUS's logo.
Ticker Symbol: MRUS

Merus N.V

$28.65 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: Netherlands Currency: USD Asset Type: Common Stock CIK:0001651311

Company Profile

Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Yalelaan 62
Website: www.merus.nl
CEO: Sven Lundberg
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $21.09
Change: -$1.40 ( -6.22%)
Days Range: $20.55 - $22.59
Beta: 0.94
52wk. High: $27.70
52wk. Low: $12.03
Ytd. Change 39.15%
50 Day Moving Average: $22.95
200 Day Moving Average: $22.95
Shares Outstanding: 49859488

Valuation

Market Cap: 105.2B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A